Keywords: astrazeneca, miss, target, crestor, filing, new, data

AstraZeneca to miss target on Crestor filing; new data to go to FDA next year

Article | 12 August 2002

Print This

AstraZeneca has said it expects to file additional data from ongoingstudies of its statin Crestor (rosuvastatin) with the US Food ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in